Trial Profile
Phase IIIB randomized study of Lexiva (FPV) [fosamprenavir] boosted with a reduced dose of ritonavir (RTF)
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 26 Sep 2006
Price :
$35
*
At a glance
- Drugs Fosamprenavir (Primary) ; Ritonavir
- Indications HIV infections
- Focus Therapeutic Use
- 26 Sep 2006 New trial record.